The intrinsic factor of cell senescence, PCBP2, was identified by unlabeled quantitative proteomics, and its biological role in in vitro replication senescence of human bone marrow mesenchymal stromal ...

In a study published in Nature Communications, researchers at the Beijing Institute of Stem Cells and Regeneration (BISCRM) ...

A novel stem cell therapy demonstrated potential in restoring the corneal surface in patients with blinding corneal injuries.

Your cornea, the eye’s outermost layer, is vital for clear vision. It relies on a steady supply of limbal epithelial stem ...

An experimental stem cell therapy reversed corneal damage in half of the participants from a recent clinical trial.

Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality.

The cornea is the transparent frontmost layer of the eye that both protects it and helps us see clearly by focusing light on ...

A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This ...

An expanded clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and ...

An expanded clinical trial that tested an experimental stem cell treatment for blinding cornea injuries found the treatment ...

Q4 2024 Earnings Call Transcript February 28, 2025 Longeveron Inc. beats earnings expectations. Reported EPS is $1.16, ...

Human stem cells can enter a suspended animation state, revealing a hidden ability with groundbreaking implications.